Too Much Cash 27YearOld With 70K in Savings Seeks Advice on Deployment SiTime Corporation SITM Plans 12 Billion Convertible Notes Offering to Fund Renesas Timing Business Acquisition Fed Rate Hike Expectations Resurface as Inflation Surge Fuels Market Pricing Data Centres Become New Frontier in Global Computing Power Arms Race Indias Parody Cockroach Party Claims Website Blocked Amid Digital Content Scrutiny Shadow Banking Surges to 147 Trillion as Regulatory Rollback Drives Bank Lending to NonBanks enGene Holdings ENGN Q1 2026 Earnings Narrower Loss Than Expected Despite No Revenue PMTS Q1 2026 Earnings EPS Misses Estimates Despite Strong Stock Rally Coterra Energy Q4 2025 Earnings EPS Misses Estimates as Commodity Headwinds Pressure Results Rigel Pharmaceuticals Q1 2026 Earnings EPS Falls Short of Expectations Astronics Q1 2026 Earnings EPS Beat Drives Positive Stock Reaction Despite Limited Revenue Disclosure PAM Q1 2026 Earnings Massive EPS Surprise Driven by Exceptional Gains Draganfly Inc DPRO Surges 168 Drone Stock Breaks Key Resistance Tests 818 Zone Syndax Pharmaceuticals SNDX Holds Steady Near 20 as Market Watches Key Levels Resideo Technologies REZI Gains 238 as Shares Approach Key Resistance Blackrock MuniYield Quality Fund III Inc MYI Rallies 15 as YieldSeekers Return Templeton Emerging Markets Fund EMF Holds Steady Near 219 Amid Consolidation Fidelity Appoints Prezzavento to ETF Strategy Role DK Q1 2026 Earnings Surprise Profit Defies Expectations as Refining Margins Improve Phio Pharmaceuticals PHIO Holds Steady at 109 as Stock Consolidates Between Key Levels Damora Therapeutics Q1 2026 Earnings WiderThanExpected Loss Despite Stock Gain Workhorse Group Q1 2026 Earnings EPS Miss Widens as Company Remains PreRevenue BCHT Q1 2026 Earnings WiderthanExpected Loss as Revenue Remains Unreported LAZ Q1 2026 Earnings Missed EPS Estimates Revenue Not Disclosed Shares Edge Higher NATH Q4 2024 Earnings EPS of 096 Reported Amid Modest Stock Reaction Performance Shipping Inc PSHG Q4 2025 Earnings Earnings Beat Despite Negative Stock Reaction RNXT Q1 2026 Earnings EPS Misses Estimates as PreRevenue Biotech Advances Pipeline